» Articles » PMID: 26135408

Emerging Potential of Exosomes and Noncoding MicroRNAs for the Treatment of Neurological Injury/diseases

Overview
Date 2015 Jul 3
PMID 26135408
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Recent discoveries of cellular generation of exosomes, small (∼ 30 - 100 nm) complex lipid membrane structures which encapsulate and transport proteins, RNAs, including microRNAs (miRNAs) have provided new insight in how cells within organisms communicate. These discoveries will likely have a major impact on the treatment of disease, with cancers and neurological diseases as evident targets. Exosomes provide a major medium of intercellular communications and thereby, there being a potential by altering communications and instructions for protein production, we can employ exosomes to treat diseases. We now have an opportunity to treat neurological disease by modifying intercellular communication networks. Recent work demonstrating that the therapeutic benefit provided by stem cells for the treatments of stroke and traumatic brain injury depend on their generation and release of exosomes provides a foundation for exosome-based therapy. Cell-free exosomes have also been recently employed to effectively treat stroke and brain trauma. The content of exosomes, particularly their miRNA cargo which can concurrently impact the post-transcriptional regulation of many genes, can be regulated. We are at the cusp of capitalizing on this important means of intercellular communications for the treatment of diseases, such as cancers and neurological diseases, among many others.

Citing Articles

Effects of extracellular vesicles for ischemic stroke: A meta‑analysis of preclinical studies.

Xie Y, Deng T, Xie L, Xie Y, Ma J, Zhong D Exp Ther Med. 2024; 28(1):287.

PMID: 38827473 PMC: 11140296. DOI: 10.3892/etm.2024.12575.


Engineered exosomes enriched with select microRNAs amplify their therapeutic efficacy for traumatic brain injury and stroke.

Chen L, Xiong Y, Chopp M, Zhang Y Front Cell Neurosci. 2024; 18:1376601.

PMID: 38566841 PMC: 10985177. DOI: 10.3389/fncel.2024.1376601.


Exploring Cardiac Exosomal RNAs of Acute Myocardial Infarction.

Jung S, Kim S, Choi J Biomedicines. 2024; 12(2).

PMID: 38398032 PMC: 10886708. DOI: 10.3390/biomedicines12020430.


Exosomes derived from microglia overexpressing miR-124-3p alleviate neuronal endoplasmic reticulum stress damage after repetitive mild traumatic brain injury.

Wang Y, Li D, Zhang L, Yin Z, Han Z, Ge X Neural Regen Res. 2024; 19(9):2010-2018.

PMID: 38227530 PMC: 11040294. DOI: 10.4103/1673-5374.391189.


Mesenchymal stem cell-derived extracellular vesicles as a cell-free therapy for traumatic brain injury via neuroprotection and neurorestoration.

Xiong Y, Mahmood A, Chopp M Neural Regen Res. 2023; 19(1):49-54.

PMID: 37488843 PMC: 10479856. DOI: 10.4103/1673-5374.374143.


References
1.
Schneider A, Simons M . Exosomes: vesicular carriers for intercellular communication in neurodegenerative disorders. Cell Tissue Res. 2012; 352(1):33-47. PMC: 3602607. DOI: 10.1007/s00441-012-1428-2. View

2.
Hu G, Drescher K, Chen X . Exosomal miRNAs: Biological Properties and Therapeutic Potential. Front Genet. 2012; 3:56. PMC: 3330238. DOI: 10.3389/fgene.2012.00056. View

3.
Zhang Z, Chopp M . Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic. Lancet Neurol. 2009; 8(5):491-500. PMC: 2727708. DOI: 10.1016/S1474-4422(09)70061-4. View

4.
Xin H, Li Y, Liu Z, Wang X, Shang X, Cui Y . MiR-133b promotes neural plasticity and functional recovery after treatment of stroke with multipotent mesenchymal stromal cells in rats via transfer of exosome-enriched extracellular particles. Stem Cells. 2013; 31(12):2737-46. PMC: 3788061. DOI: 10.1002/stem.1409. View

5.
Pennypacker K, Offner H . The role of the spleen in ischemic stroke. J Cereb Blood Flow Metab. 2014; 35(2):186-7. PMC: 4426754. DOI: 10.1038/jcbfm.2014.212. View